INHIBITION OF ACYL-COA - CHOLESTEROL ACYLTRANSFERASE ACTIVITY BY CYCLODEPSIPEPTIDE ANTIBIOTICS

被引:159
作者
TOMODA, H
HUANG, XH
CAO, J
NISHIDA, H
NAGAO, R
OKUDA, S
TANAKA, H
OMURA, S
ARAI, H
INOUE, K
机构
[1] KITASATO INST, BIOL FUNCT RES CTR, MINATO KU, TOKYO 108, JAPAN
[2] KITASATO UNIV, SCH PHARMACEUT SCI, MINATO KU, TOKYO 108, JAPAN
[3] UNIV TOKYO, FAC PHARMACEUT SCI, BUNKYO KU, TOKYO 113, JAPAN
关键词
D O I
10.7164/antibiotics.45.1626
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The effect was studied of the fungal cyclodepsipeptide antibiotics beauvericin and seven distinct enniatins on acyl-CoA: cholesterol acyltransferase (ACAT) activity. In an enzyme assay using rat liver microsomes. all the compounds were found to inhibit ACAT activity. The drug concentration that caused 50% inhibition (IC50 value) of the enzyme activity was determined to be 3.0 mum for beauvericin, indicating that the compound is one of the most potent ACAT inhibitors of microbial origin. Enniatins exhibited much higher IC50 values of 22 to 110 mum. More hydrophobic enniatins showed more potent inhibitory activity. Furthermore, the ACAT inhibitory activity was evaluated as inhibition of cholesteryl ester formation in a cell assay using J774 macrophages. Calculation of the ratio, CD50 value (the drug concentration causing 50% cell damage)/IC50 value of cholesteryl ester formation, indicated thal beauvericin shows the highest specificity. These data indicate that beauvericin is one of the most potent and specific ACAT inhibitors of microbial origin.
引用
收藏
页码:1626 / 1632
页数:7
相关论文
共 50 条
[11]   ROLE OF ACYL-COA - CHOLESTEROL ACYLTRANSFERASE IN CELLULAR CHOLESTEROL-METABOLISM [J].
SUCKLING, KE ;
STANGE, EF .
JOURNAL OF LIPID RESEARCH, 1985, 26 (06) :647-671
[12]   The Selectivity of Beauveriolide Derivatives in Inhibition toward the Two Isozymes of Acyl-CoA : cholesterol Acyltransferase [J].
Ohshiro, Taichi ;
Matsuda, Daisuke ;
Nagai, Kenichiro ;
Doi, Takayuki ;
Sunazuka, Toshiaki ;
Takahashi, Takashi ;
Rudel, Lawrence Lee ;
Omura, Satoshi ;
Tomoda, Hiroshi .
CHEMICAL & PHARMACEUTICAL BULLETIN, 2009, 57 (04) :377-381
[13]   Selectivity of Pyripyropene Derivatives in Inhibition toward Acyl-CoA:cholesterol Acyltransferase 2 Isozyme [J].
Taichi Ohshiro ;
Satoshi Ohte ;
Daisuke Matsuda ;
Masaki Ohtawa ;
Tohru Nagamitsu ;
Toshiaki Sunazuka ;
Yoshihiro Harigaya ;
Lawrence L Rudel ;
Satoshi Ōmura ;
Hiroshi Tomoda .
The Journal of Antibiotics, 2008, 61 :503-508
[14]   Selectivity of pyripyropene derivatives in inhibition toward acyl-CoA:cholesterol acyltransferase 2 isozyme [J].
Ohshiro, Taichi ;
Ohte, Satoshi ;
Matsuda, Daisuke ;
Ohtawa, Masaki ;
Nagamitsu, Tohru ;
Sunazuka, Toshiaki ;
Harigaya, Yoshihiro ;
Rudel, Lawrence L. ;
Omura, Satoshi ;
Tomoda, Hiroshi .
JOURNAL OF ANTIBIOTICS, 2008, 61 (08) :503-508
[15]   Acyl-CoA: Cholesterol acyltransferase inhibition prevents oxysterol-induced apoptosis in macrophages [J].
Freeman, NE ;
Sinensky, MS ;
Rusinol, AE ;
Thewke, DP .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (05) :E43-E43
[16]   Update on the role of acyl-CoA:cholesterol acyltransferase inhibitors in atherosclerosis [J].
Doshi, R ;
Wu, J ;
Fishelevich, R ;
Rodriguez, A .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2001, 11 (11) :1655-1662
[17]   Glibenclamide acts as an inhibitor of acyl-CoA:cholesterol acyltransferase enzyme [J].
Ohgami, N ;
Kuniyasu, A ;
Furukawa, K ;
Miyazaki, A ;
Hakamata, H ;
Horiuchi, S ;
Nakayama, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 277 (02) :417-422
[18]   ACYL-COA - CHOLESTEROL ACYLTRANSFERASE IN HUMAN SMALL-INTESTINE [J].
HELGERUD, P ;
LILLJEQVIST, AC ;
NORDBY, G ;
NORUM, KR .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1979, 9 (02) :15-15
[19]   Chlamydia trachomatis growth depends on eukaryotic cholesterol esterification and is affected by Acyl-CoA: cholesterol acyltransferase inhibition [J].
Peters, Jan ;
Byrne, Gerald I. .
PATHOGENS AND DISEASE, 2015, 73 (06)
[20]   Acyl-CoA: Cholesterol acyltransferase inhibitors from flex macropoda [J].
Im, KR ;
Jeong, TS ;
Kwon, BM ;
Baek, NI ;
Kim, SH ;
Kim, DK .
ARCHIVES OF PHARMACAL RESEARCH, 2006, 29 (03) :191-194